Ricci, Enzo
 Distribuzione geografica
Continente #
EU - Europa 5.190
NA - Nord America 4.505
AS - Asia 1.918
SA - Sud America 410
AF - Africa 44
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 5
Totale 12.097
Nazione #
US - Stati Uniti d'America 4.403
DE - Germania 1.799
CN - Cina 762
SE - Svezia 761
SG - Singapore 692
IT - Italia 574
PL - Polonia 443
UA - Ucraina 431
BR - Brasile 377
IE - Irlanda 231
GB - Regno Unito 229
FR - Francia 223
FI - Finlandia 202
ID - Indonesia 148
RU - Federazione Russa 92
IN - India 91
CA - Canada 63
TR - Turchia 58
NL - Olanda 42
HK - Hong Kong 33
BE - Belgio 32
ES - Italia 30
JP - Giappone 25
VN - Vietnam 24
AT - Austria 22
AU - Australia 22
MX - Messico 22
CI - Costa d'Avorio 20
KR - Corea 19
IR - Iran 16
CH - Svizzera 15
AR - Argentina 13
BD - Bangladesh 11
CZ - Repubblica Ceca 10
MA - Marocco 8
UZ - Uzbekistan 8
ZA - Sudafrica 8
EC - Ecuador 7
RO - Romania 7
SK - Slovacchia (Repubblica Slovacca) 6
BG - Bulgaria 5
CL - Cile 5
LT - Lituania 5
LV - Lettonia 5
PA - Panama 5
PT - Portogallo 5
GR - Grecia 4
AM - Armenia 3
BZ - Belize 3
DK - Danimarca 3
DZ - Algeria 3
EG - Egitto 3
HU - Ungheria 3
LU - Lussemburgo 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
PE - Perù 3
PR - Porto Rico 3
TH - Thailandia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BN - Brunei Darussalam 2
DO - Repubblica Dominicana 2
EE - Estonia 2
EU - Europa 2
HN - Honduras 2
IL - Israele 2
KZ - Kazakistan 2
MN - Mongolia 2
PH - Filippine 2
PY - Paraguay 2
SA - Arabia Saudita 2
A1 - Anonimo 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
CY - Cipro 1
GE - Georgia 1
GY - Guiana 1
IQ - Iraq 1
IS - Islanda 1
JM - Giamaica 1
KE - Kenya 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MY - Malesia 1
PK - Pakistan 1
QA - Qatar 1
TM - Turkmenistan 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
VE - Venezuela 1
Totale 12.097
Città #
Chandler 779
Warsaw 424
Singapore 405
Ashburn 398
Jacksonville 254
San Mateo 237
Munich 230
Dublin 224
Nanjing 153
Wilmington 147
Jakarta 146
Ann Arbor 145
Woodbridge 122
Houston 114
Nürnberg 114
Fairfield 111
New York 109
Boston 100
Helsinki 99
Rome 98
Dearborn 94
Milan 88
Moscow 71
Seattle 68
Lawrence 67
Princeton 63
Redwood City 63
Nanchang 61
Cattolica 59
Beijing 48
Bremen 46
Chicago 44
Izmir 43
Los Angeles 43
Chengdu 37
Marseille 37
Cambridge 34
Ottawa 34
Shenyang 34
Hebei 31
Redmond 29
São Paulo 28
Frankfurt am Main 27
Hangzhou 27
Mountain View 27
University Park 27
Jiaxing 26
Kunming 26
San Jose 26
Boardman 25
Hefei 25
Changsha 23
Leawood 23
Norwalk 22
Detroit 21
Hong Kong 21
Nuremberg 21
Abidjan 20
Belo Horizonte 20
Lancaster 20
Shanghai 20
Washington 20
Brussels 19
Düsseldorf 19
Sydney 18
Madrid 17
Seoul 17
The Dalles 17
Tianjin 17
Fremont 16
London 15
Saint Louis 15
Toronto 15
Zhengzhou 15
Las Vegas 14
Guangzhou 13
Inverigo 13
North Bergen 13
Rio de Janeiro 13
Vienna 12
Berlin 10
Palermo 10
Pune 10
Augusta 9
Curitiba 9
Jyväskylä 9
Kraków 9
Paris 9
Bologna 8
Hanoi 8
Kish 8
Lanzhou 8
Ningbo 8
Philadelphia 8
Phoenix 8
San Francisco 8
Andover 7
Antwerp 7
Busto Arsizio 7
Florence 7
Totale 6.443
Nome #
Potential therapeutic targets for ALS: MIR206, MIR208b and MIR499 are modulated during disease progression in the skeletal muscle of patients 339
MyoD expression restores defective myogenic differentiation of human mesoangioblasts from inclusion-body myositis muscle. 330
An immunological analysis of dystroglycan subunits: lessons learned from a small cohort of non-congenital dystrophic patients. 294
Balance and walking in facioscapulohumeral muscular dystrophy: multiperspective assessment 216
A case of CMT 1B due to Val 102/fs null mutation of the MPZ gene presenting as hyperCKemia 205
Sleeep quality in Facioscapulohumeral muscular dystrophy. 204
Upper body involvement in GNE myopathy assessed by muscle imaging 204
Alternative splicing alterations of Ca(2+) handling genes are associated with Ca(2+) signal dysregulation in DM1 and DM2 myotubes 203
CD8(+) T Cells in Facioscapulohumeral Muscular Dystrophy Patients with Inflammatory Features at Muscle MRI 173
Hospital admissions from the emergency department of adult patients affected by myopathies 169
Cephalometric findings in facioscapulohumeral muscular dystrophy patients with obstructive sleep apneas 159
Balance and walking involvement in Facioscapulohumeral Muscular Dystrophy (FSHD): a pilot study on the effects of custom lower limb orthoses 155
Tracking muscle wasting and disease activity in facioscapulohumeral muscular dystrophy by qualitative longitudinal imaging 155
Decreased nocturnal movements in patients with facioscapulohumeral muscular dystrophy 152
alpha-Dystroglycan does not play a major pathogenic role in autosomal recessive hereditary inclusion-body myopathy 150
Heart rate variability in facioscapulohumeral muscular dystrophy. 149
Pain and the Alpha-Sleep Anomaly: A Mechanism of Sleep Disruption in Facioscapulohumeral Muscular Dystrophy 149
Analysis of ryanodine receptor 1 (RyR1) and voltage-gated Ca2+ channel (VGCC) alpha1S subunit (Cav1.1) pre-mRNA splicing and correlation with intracellular calcium signals in myotonic dystrophy type 1 (DM1) and in myotonic dystrophy type 2 (DM2) myotubes. 147
Chronic GM2 gangliosidosis type Sandhoff associated with a novel missense HEXB gene mutaton causing a double patogenetic effect 144
Muscle imaging findings in GNE myopathy 138
Sleep quality in Facioscapulohumeral muscular dystrophy 138
Quality of Life and Pain assessment in patients with facioscapulohumeral muscular dystrophy 135
Alternative splicing alterations of Ca2+ handling genes are associated with Ca2+ signal dysregulation in myotonic dystrophy type 1 (DM1) and type 2 (DM2) myotubes. 126
Monoclonal antibody fragment from combinatorial phage display library neutralizes alpha-latrotoxin activity and abolishes black widow spider venom lethality, in mice 125
Mesoangioblasts from Facioscapulohumeral Muscular Dystrophy display in vivo a variable myogenic ability predictable by their in vitro behavior. 124
Muscle MRI in Becker muscular dystrophy 124
Myotonic dystrophy type 1 and de novo FSHD mutation double trouble: A clinical and muscle MRI study 124
Mitochondrial network genes in the skeletal muscle of amyotrophic lateral sclerosis patients. 122
Sporadic late-onset nemaline myopathy: clinical, pathology and imaging findings in a single center cohort 119
Muscle MRI in female carriers of dystrophinopathy 115
An Italian Neurology Outpatient Clinic Facing SARS-CoV-2 Pandemic: Data From 2,167 Patients 114
Congenital muscular dystrophies with defective glycosylation of dystroglycan: a population study 113
Muscle MRI in Becker muscular dystrophy 112
Hyposialylation of neprilysin possibly affects its expression and enzymatic activity in hereditary inclusion-body myopathy muscle 109
Truncation of Caveolin-3 causes autosomal-recessive Rippling Muscle Disease 107
Progressive multifocal leukoencephalopathy in a patient with Franklin disease and hypogammaglobulinemia. 107
Congenital muscular dystrophies with cognitive impairment. A population study 107
Upper Girdle Imaging in Facioscapulohumeral Muscular Dystrophy 106
Non-myogenic mesenchymal cells contribute to muscle degeneration in facioscapulohumeral muscular dystrophy patients 105
Different molecular signatures in magnetic resonance imaging-staged facioscapulohumeral muscular dystrophy muscles 103
Magnetic Resonance Imaging in a large cohort of facioscapulohumeral muscular dystrophy patients: pattern refinement and implications for clinical trials 98
Analysis of NCAM helps identify unusual phenotypes of hereditary inclusion-body myopathy 97
Coeliac disease presenting with acute disseminated encephalomyelitis 96
New phenotype and pathology features in MYH7-related distal myopathy 94
Limb-girdle muscular dystrophy with α-dystroglycan deficiency and mutations in the ISPD gene 94
Neprilysin participates in skeletal muscle regeneration and is accumulated in abnormal muscle fibres of inclusion body myositis. 93
Sleep disordered breathing in facioscapulohumeral muscular dystrophy. 93
Estrogens enhance myoblast differentiation in facioscapulohumeral muscular dystrophy by antagonizing DUX4 activity 90
Allele-specific DNA hypomethylation characterises FSHD1 and FSHD2 88
Diagnostic magnetic resonance imaging biomarkers for facioscapulohumeral muscular dystrophy identified by machine learning 87
Ocular palsies in the absence of other neurological or ocular symptoms: analysis of 105 cases 86
Analysis of MTMR1 expression and correlation with muscle pathological features in juvenile/adult onset myotonic dystrophy type 1 (DM1) and in myotonic dystrophy type 2 (DM2). 86
Calf muscle involvement in Becker muscular dystrophy: When size does not matter 86
Cerebellar degeneration and ocular myasthenia gravis in a patient with recurring ovarian carcinoma. 84
Remitting-Relapsing Carbamazepine Overdosage Mimicking Vertebrobasilar Transient Ischemic Attacks 84
MRI neurography findings in patients with idiopathic brachial plexopathy: correlations with clinical-neurophysiological data in eight consecutive cases 83
Long-term Follow-up and Muscle Imaging Findings in Brachio-Cervical Inflammatory Myopathy 83
Expanding the clinical-pathological and genetic spectrum of RYR1-related congenital myopathies with cores and minicores: an Italian population study 83
An Italian case of hereditary myopathy with early respiratory failure (HMERF) not associated with the titin kinase domain R279W mutation 82
Coeliac disease presenting with acute disseminated encephalomyelitis. 80
Teaching video neuroimages: complicated scapular winging 80
Deep phenotyping of facioscapulohumeral muscular dystrophy type 2 by magnetic resonance imaging 80
Severe 5,10-methylenetetrahydrofolate reductase deficiency: A rare, treatable cause of complicated hereditary spastic paraplegia 79
Increased aging in primary muscle cultures of sporadic inclusion-body myositis. 76
An Italian family with autosomal recessive inclusion-body myopathy and mutations in the GNE gene 75
MRI in sarcoglycanopathies: a large international cohort study 74
Proteomics of muscle microdialysates identifies potential circulating biomarkers in facioscapulohumeral muscular dystrophy 74
Prevalence of congenital muscular dystrophy in Italy: a population study 71
Magnetic resonance imaging pattern recognition in sporadic Inclusion-Body Myositis 70
Muscle hypertrophy in amyloid myopathy 69
Muscle fibrosis as a prognostic biomarker in facioscapulohumeral muscular dystrophy: a retrospective cohort study 68
Upper girdle imaging in facioscapulohumeral muscular dystrophy 68
Muscle magnetic resonance imaging in myotonic dystrophy type 1 (DM1): Refining muscle involvement and implications for clinical trials 68
Pilot trial of simvastatin in the treatment of sporadic inclusion-body myositis 67
Mixed connective tissue disease presenting as a peculiar myositis with poor muscle regeneration 67
An Exceptional Case of Acute Respiratory Failure Caused by Intra-Thoracic Gastric Perforation Secondary to Overeating 67
MRI neurography findings in patients with idiopathic brachial plexopathy: correlations with clinical-neurophysiological data in eight consecutive cases 66
To the Editor: Fasciculations in Late-Onset Pompe Disease: A Sign of Motor Neuron Involvement? 66
Surgical Decision-Making in Spinal Instability in Facioscapulohumeral Muscular Dystrophy Related with a Spinal Muscle Atrophy 66
Dynamic magnetic resonance imaging of muscle contraction in facioscapulohumeral muscular dystrophy 65
An Italian Neurology Outpatient Clinic Facing SARS-CoV-2 Pandemic: Data From 2,167 Patients 64
Mouth leaks may complicate positive airway pressure treatment of OSAS in facioscapulohumeral muscular dystrophy. 63
Gene expression profiling in the early phases of DMD: a constant molecular signature characterizes DMD muscle from early postnatal life throughout disease progression. 62
'Pathognomonic' muscle imaging findings in DNAJB6 mutated LGMD1D 61
Somatic mosaicism in TPM2-related myopathy with nemaline rods and cap structures. 60
Music exposure differentially alters the levels of brain-derived neurotrophic factor and nerve growth factor in the mouse hypothalamus. 59
A standardized clinical evaluation of patients affected by facioscapulohumeral muscular dystrophy: The FSHD clinical score. 59
Muscle magnetic resonance imaging in myotonic dystrophy type 1 (DM1): Refining muscle involvement and implications for clinical trials 59
Muscle magnetic resonance imaging in myotonic dystrophy type 1 (DM1): Refining muscle involvement and implications for clinical trials 59
Technology outcome measures in neuromuscular disorders: A systematic review 59
European muscle MRI study in limb girdle muscular dystrophy type R1/2A (LGMDR1/LGMD2A) 58
The genetic basis of undiagnosed muscular dystrophies and myopathies 57
Long-term Follow-up and Muscle Imaging Findings in Brachio-Cervical Inflammatory Myopathy 57
Estimating the impact of COVID-19 pandemic on services provided by Italian Neuromuscular Centers: an Italian Association of Myology survey of the acute phase 55
Dystrophin quantification and clinical correlations in Becker muscular dystrophy: implications for clinical trials 54
Ultrasound Tissue Characterization Does Not Differentiate Genotype, But Indexes Ejection Fraction Deterioration in Becker Muscular Dystrophy 54
Muscle imaging in patients with tubular aggregate myopathy caused by mutations in STIM1 54
Muscle Microdialysis to Investigate Inflammatory Biomarkers in Facioscapulohumeral Muscular Dystrophy 54
Large scale genotype-phenotype analyses indicate that novel prognostic tools are required for families with facioscapulohumeral muscular dystrophy 53
Concentric muscle involvement in POLG-related distal myopathy 53
Totale 10.507
Categoria #
all - tutte 54.152
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.152


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020111 0 0 0 0 0 0 0 0 0 0 0 111
2020/20211.109 36 113 26 118 146 45 139 22 161 54 211 38
2021/20221.235 92 94 30 87 49 70 22 194 88 61 213 235
2022/20232.272 283 289 193 330 178 298 76 177 302 29 57 60
2023/20241.317 50 340 40 81 37 167 115 72 20 54 174 167
2024/20252.387 67 87 233 62 207 138 177 206 441 228 506 35
Totale 12.270